Blueprint Medicines Corp (BPMC): Biotechnology Value Fund Reports 10.4% Stake

Page 3 of 11

Page 3 of 11 – SEC Filing

1
NAME OF REPORTING PERSON
BVF Partners L.P.
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
  (a) x
  (b) o
3
SEC USE ONLY
4
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5
SOLE VOTING POWER
0 shares
6
SHARED VOTING POWER
2,840,251
7
SOLE DISPOSITIVE POWER
0 shares
8
SHARED DISPOSITIVE POWER
2,840,251
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,840,251
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
¨
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
10.4%
12
TYPE OF REPORTING PERSON
 
PN, IA

Follow Blueprint Medicines Corp (NASDAQ:BPMC)

Page 3 of 11